Volume 9, 2022
Volume 9, 2022 is now on PubMed »
About the CoverThe cover for Oncoscience Volume 9, 2022 features Figure 2, "As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression" from https://doi.org/10.18632/oncoscience.561 |
Research Papers
Systemic lipid peroxidation profile from patients with breast cancer changes according to the lymph nodal metastasis status
https://doi.org/10.18632/oncoscience.550
Stefania Tagliari de Oliveira, Monica Pavaneli Bessani, Thalita Basso Scandolara, Janaína Carla Silva, Aedra Carla Bufalo Kawassaki, Pâmella Aparecida Ferreira Fagotti, Vitor Teixeira Maito, Janoário Athanazio de Souza, Daniel Rech, Carolina Panis
p 1-10
Abstract | PDF | Full Text | How to Cite
Editorials
β-Galactosylceramidase in cancer: more than a psychosine scavenger
https://doi.org/10.18632/oncoscience.551
Mirella Belleri, Marco Presta
p 11-12
Research Perspectives
Altos Labs and the quest for immortality: but can we live longer right now?
https://doi.org/10.18632/oncoscience.552
Mikhail V. Blagosklonny
p 13-16
Editorials
Towards the prevention of childhood leukemia
https://doi.org/10.18632/oncoscience.553
Kim E. Nichols, Isidro Sánchez-García
p 17-19
Research Perspectives
HSP90 as an emerging barrier to immune checkpoint blockade therapy
https://doi.org/10.18632/oncoscience.554
Daolin Tang, Rui Kang
p 20-22
Editorials
Epigenetics and cancer disparities: when nature might be nurture
https://doi.org/10.18632/oncoscience.555
I. King Jordan, Kara K. Lee, John F. McDonald, Leonardo Mariño-Ramírez
p 23-24
Editorials
Crosstalk between KIF15 and AR in castrate-resistant prostate cancers
https://doi.org/10.18632/oncoscience.556
Hanny Yang , Xuesen Dong
p 25-26
Research Perspectives
A CRISPR-p53 interactome with potential implications for clinical CRISPR/Cas9 use
https://doi.org/10.18632/oncoscience.557
Long Jiang, Fredrik Wermeling
p 27-29
Research Perspectives
Potential roles of FAT1 somatic mutation in progression of head and neck cancer
https://doi.org/10.18632/oncoscience.558
Zhuo G. Chen, Yong Teng
p 30-32
Research Perspectives
Circulating tumor DNA as a therapy response marker in metastatic colorectal cancer
https://doi.org/10.18632/oncoscience.559
Xiaoju Max Ma, Stephanie J. Yaung
p 33-34
Research Perspectives
SLFN11’s surveillance role in protein homeostasis
https://doi.org/10.18632/oncoscience.560
Yasuhisa Murai, Ukhyun Jo, Yasuhiro Arakawa, Naoko Takebe, Yves Pommier
p 35-37
Commentary
As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression
https://doi.org/10.18632/oncoscience.561
Mikhail V. Blagosklonny
p 38-41
PDF | Full Text | How to Cite
Research Perspectives
Leveraging the scientific findings to develop therapeutic strategies for dormant breast cancer cells
https://doi.org/10.18632/oncoscience.562
Alejandra Ferrer, Yannick Kenfack, Andrew Petryna, Wadih Arap, Renata Pasqualini, Pranela Rameshwar
p 42-48
Research Perspectives
lncRNA HOTAIR functions and therapeutic perspectives
https://doi.org/10.18632/oncoscience.563
Sabrina Garbo, Marco Tripodi, Cecilia Battistelli
p 49-51
Editorials
MicroRNAs as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much is missing?
https://doi.org/10.18632/oncoscience.564
Laura Gramantieri, Francesca Fornari
p 52-54
Editorials
Phenotypic heterogeneity and cooperation in the metastatic cascade
https://doi.org/10.18632/oncoscience.565
Katherine M. Young, Cynthia A. Reinhart-King
p 55-56
Editorials
GM-CSF - an oncogenic driver of HER2+ breast leptomeningeal metastasis
https://doi.org/10.18632/oncoscience.566
Rachana Garg, Kai Jandial, Mike Chen
p 57-59
Research Perspectives
A murine model for human early/immature T-cell precursor acute lymphoblastic leukemia (EITP ALL)
https://doi.org/10.18632/oncoscience.567
Vijay Negi, Peter D. Aplan
p 60-63
Editorials
Ikaros as a downstream mediator of BCR blockade therapy in B-cell non-Hodgkin lymphoma
https://doi.org/10.18632/oncoscience.568
Marcelo Lima Ribeiro, Emmanuel Normant, Gaël Roué
p 64-65
Research Perspectives
Modulation of heme and tumor vascular oxygenation- a novel strategy for lung cancer therapy
https://doi.org/10.18632/oncoscience.569
Poorva Ghosh, Ralph P. Mason, Li Liu, Li Zhang
p 66-69
Research Papers
Association between tumor mutations and meningioma recurrence in Grade I/II disease
https://doi.org/10.18632/oncoscience.570
Jonathan T. Dullea, Vikram Vasan, John W. Rutland, Corey M. Gill, Danielle Chaluts, Daniel Ranti, Ethan Ellis, Varun Subramanium, Annie Arrighi-Allisan, Yayoi Kinoshita, Russell B. McBride, Joshua Bederson, Michael Donovan, Robert Sebra, Melissa Umphlett, Raj K. Shrivastava
p 70-81
Abstract | PDF | Full Text | Supplementary Materials | How to Cite | Press Release
Research Perspectives
Rapamycin in the context of Pascal’s Wager: generative pre-trained transformer perspective
https://doi.org/10.18632/oncoscience.571
ChatGPT Generative Pre-trained Transformer, Alex Zhavoronkov
p 82-84